The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data.

Pyrsopoulos, Nikolaos

The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data. [electronic resource] - European journal of gastroenterology & hepatology 07 2018 - 761-765 p. digital

Publication Type: Journal Article; Observational Study

1473-5687

10.1097/MEG.0000000000001101 doi


Antiviral Agents--adverse effects
Benzimidazoles--adverse effects
Female
Fluorenes--adverse effects
Hepacivirus--drug effects
Hepatitis C--diagnosis
Humans
Immunosuppressive Agents--therapeutic use
Liver Cirrhosis--diagnosis
Liver Transplantation--adverse effects
Male
Middle Aged
Recurrence
Retrospective Studies
Ribavirin--adverse effects
Sofosbuvir
Sustained Virologic Response
Time Factors
Treatment Outcome
Uridine Monophosphate--adverse effects
Virus Activation--drug effects